Award

U10-CA038926

Funded outputs count: 225

Funder award ID: U10-CA038926

OpenAlex ID: G379387698

Genome‐wide study of genetic polymorphisms predictive for outcome from first‐line oxaliplatin‐based chemotherapy in colorectal cancer patients

2023 · Hanla A. Park, Dominic Edelmann, et al. · International Journal of Cancer · 4

PDF

Predictive Polygenic Score for Outcome after First-Line Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients Using Supervised Principal Component Analysis

2022 · Hanla A. Park, Dominic Edelmann, et al. · Cancer Epidemiology Biomarkers & Prevention · 4

PDF

Race-Dependent Differences in Risk, Genomics, and Epstein–Barr Virus Exposure in Monoclonal Gammopathies: Results of SWOG S0120

2020 · Madhav V. Dhodapkar, Rachael Sexton, et al. · Clinical Cancer Research · 8

PDF

The relationship between clinical trial accrual volume and outcomes in acute myeloid leukemia: A SWOG/ECOG-ACRIN study (S0106 and E1900)

2019 · Bruno C. Medeiros, Megan Othus, et al. · Leukemia Research · 3

Patient-reported outcomes for patients with metastatic castration-resistant prostate cancer receiving docetaxel and Atrasentan versus docetaxel and placebo in a randomized phase III clinical trial (SWOG S0421)

2018 · Joseph M. Unger, Katherine Griffin, et al. · Journal of Patient-Reported Outcomes · 12

PDF

High frequency of brain metastases after adjuvant therapy for high‐risk melanoma

2017 · Wolfram E. Samlowski, James Moon, et al. · Cancer Medicine · 35

PDF

Case-only Approach to Identifying Markers Predicting Treatment Effects on the Relative Risk Scale

2017 · James Y. Dai, C. Jason Liang, et al. · Biometrics · 11

Paired Phase II Studies of Erlotinib/Bevacizumab for Advanced Bronchioloalveolar Carcinoma or Never Smokers With Advanced Non–Small-cell Lung Cancer: SWOG S0635 and S0636 Trials

2017 · Howard L. West, James Moon, et al. · Clinical Lung Cancer · 8

PDF

Validation of the Association of RECIST Changes With Survival in Men With Metastatic Castration-Resistant Prostate Cancer Treated on SWOG Study S0421

2017 · Guru Sonpavde, Gregory R. Pond, et al. · Clinical Genitourinary Cancer · 6

Next-Generation Sequencing in Adult B Cell Acute Lymphoblastic Leukemia Patients

2017 · Olga Sala Torra, Megan Othus, et al. · Transplantation and Cellular Therapy · 63

PDF

Seven-year follow-up for energy/vitality outcomes in early stage Hodgkin’s disease patients treated with subtotal lymphoid irradiation versus chemotherapy plus radiation: SWOG S9133 and its QOL companion study, S9208

2016 · Carol M. Moinpour, Joseph M. Unger, et al. · Journal of Cancer Survivorship · 7

Prediction of CR following a second course of ‘7+3’ in patients with newly diagnosed acute myeloid leukemia not in CR after a first course

2016 · M Othus, S Mukherjee, et al. · Leukemia · 25

Disease Control Rate at 8 Weeks Predicts Subsequent Survival in Platinum-Treated Extensive Stage Small-Cell Lung Cancer: Results From the Southwest Oncology Group (SWOG) Database

2015 · Primo N. Lara, James Moon, et al. · Clinical Lung Cancer · 13

PDF

Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG

2015 · R. B. Walter, M. Othus, et al. · Haematologica · 12

Phase II Intergroup Trial of Alisertib in Relapsed and Refractory Peripheral T-Cell Lymphoma and Transformed Mycosis Fungoides: SWOG 1108

2015 · Paul M. Barr, Hongli Li, et al. · Journal of Clinical Oncology · 114

PDF

Randomized Phase III Trial Comparing ABVD Plus Radiotherapy With the Stanford V Regimen in Patients With Stages I or II Locally Extensive, Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the North American Intergroup E2496 Trial

2015 · Ranjana H. Advani, Fangxin Hong, et al. · Journal of Clinical Oncology · 36

PDF

Cell Signaling-Based Classifier Predicts Response to Induction Therapy in Elderly Patients with Acute Myeloid Leukemia

2015 · Alessandra Cesano, Cheryl L. Willman, et al. · PLoS ONE · 5

PDF

Low Serum Vitamin D Levels Are Associated With Inferior Survival in Follicular Lymphoma: A Prospective Evaluation in SWOG and LYSA Studies

2015 · Jennifer L. Kelly, Gilles Salles, et al. · Journal of Clinical Oncology · 77

Prognostic Significance of NPM1 Mutations in the Absence of FLT3 –Internal Tandem Duplication in Older Patients With Acute Myeloid Leukemia: A SWOG and UK National Cancer Research Institute/Medical Research Council Report

2015 · Fabiana Ostronoff, Megan Othus, et al. · Journal of Clinical Oncology · 132

SWOG S0722: Phase II Study of mTOR Inhibitor Everolimus (RAD001) in Advanced Malignant Pleural Mesothelioma (MPM)

2015 · Sai-Hong Ignatius Ou, James Moon, et al. · Journal of Thoracic Oncology · 80

Pharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation

2015 · Pierre Bohanes, Cathryn J. Rankin, et al. · Clinical Cancer Research · 11

PDF

A Pilot Trial of Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Docetaxel and the Combination of Bevacizumab (NSC-704865) in Patients With Inoperable Locally Advanced Stage III Non–Small-Cell Lung Cancer: SWOG S0533

2015 · Antoinette J. Wozniak, James Moon, et al. · Clinical Lung Cancer · 49

PDF

Fate of Patients with Newly Diagnosed Acute Myeloid Leukemia Who Fail Primary Induction Therapy

2014 · Megan Othus, Frederick R. Appelbaum, et al. · Transplantation and Cellular Therapy · 79

PDF

Cytogenetic heterogeneity negatively impacts outcomes in patients with acute myeloid leukemia

2014 · B. C. Medeiros, M. Othus, et al. · Haematologica · 29

PDF

Relevance of Platinum-Sensitivity Status in Relapsed/Refractory Extensive-Stage Small-Cell Lung Cancer in the Modern Era: A Patient-Level Analysis of Southwest Oncology Group Trials

2014 · Primo N. Lara, James Moon, et al. · Journal of Thoracic Oncology · 27